Navigation Links
IRIDEX Reports 2011 Fourth Quarter and Year-End Results

statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Act of 1934, as amended, relating to the Company's growth strategy, MicroPulse laser therapy, revenue growth and the Company's projected fiscal 2012 financial results.  These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors.  Please see a detailed description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended January 1, 2011 and our Quarterly Reports on Form 10-Q for the quarters ended April 2, 2011, July 2, 2011 and October 1, 2011, each of which was filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and will not be updated.TABLES FOLLOWIRIDEX CorporationCondensed Consolidated Statements of Operations(In thousands, except per share data)

(unaudited)Three Months EndedTwelve Months EndedDecember 31,January 1, December 31,January 1, 2011201120112011Total revenues

32,308Cost of revenues

4,3424,57316,86916,106Gross profit

4,2784,46416,29016,202Operating expenses:Research and development

1,1668853,9133,753Sales and marketing

2,1472,0947,4587,095General and administrative

1,0669234,2594,163Legal settlement, net of expenses

(1,274)-(1,274)-Total operating expenses

3,1053,90214,35615,011Income from operations

1,1735621,9341,191Other income (expense)Legal settlement

--800800Interest and other income (expense), net

(250)4(296)(30)Total other income (expense)

(250)4504770Income from continuing operations before income taxes

9235662,4381,961Provision for income taxes

122322297308Income from continuing operations

8012442,1411,653Income (lo

Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. IRIDEX Announces Fourth Quarter and Full Year 2011 Conference Call and Release Date
2. IRIDEX MicroPulse™ Laser Therapy Enhances Visual Function in Patients with Central Serous Chorioretinopathy (CSC)
3. IRIDEX to Present at the Sidoti & Company New York Micro Cap Conference
4. Cutera and IRIDEX Announce Acquisition of IRIDEX Aesthetic Business Unit
5. 10-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema
6. IRIDEX Signs License and Distribution Agreement with Leader in Eye Care
7. IRIDEX Reports 2011 Third Quarter and Nine-Month Results
8. IRIDEX Announces Third Quarter 2011 Conference Call and Release Date
9. IRIDEX Launches New MicroPulse™ Module Targeting the Broad Ophthalmology Laser Photocoagulation Market
10. IRIDEX Names Veteran Healthcare Executive Dominik Beck President, CEO
11. IRIDEX Licenses the Exclusive Rights to Ophthalmology Products and Intellectual Property from Ocunetics, Inc.
Post Your Comments:
(Date:8/22/2014)... , Aug. 22, 2014  Cannabis Science, ... cannabis formulation-based drug development and related consulting, is ... third international medical cannabis conference taking place at ... France , on October 22, 2014.  The ... stakeholders, such as researchers, health professionals, and patients, ...
(Date:8/22/2014)... , Aug. 22, 2014 /PRNewswire/ - SQI ... that develops and commercializes proprietary technologies and products ... has entered into a Master Service Agreement to ... DNA-based pathogen detection assays. During the initial phase ... deliver an automated working prototype of one of ...
(Date:8/21/2014)... Conn. , Aug. 21, 2014  Aptuit ... West Lafayette, Indiana , has enhanced ... and characterization of small and large molecules, including ... of the Bruker maXisPlus Q-TOF mass spectrometer. ... Goldman , CEO, Aptuit, said, "The expanded large ...
Breaking Medicine Technology:Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 2Cannabis Science, Inc. (CBIS) to Sponsor 3rd International Conference on Cannabinoids in Medicine in October 2014 in Strasbourg, France 3SQI Diagnostics Contracted to Automate Pathogen Detection Assays 2SQI Diagnostics Contracted to Automate Pathogen Detection Assays 3Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2
... 6 TargeGen, Inc. today announced that,the Company,s ... and the,Company plans to initiate a multi-center clinical ... highly selective JAK2 inhibitor in,January, 2008. Additionally, TargeGen ... will be made at the 2007 ASH Conference,(Atlanta, ...
... Inc. (Nasdaq: BCRX ) today provided an ... Forodesine HCl Data to be Presented at American ... Chair, Dermatology, The University of,Texas M.D. Anderson Cancer ... Phase I/II clinical study of oral forodesine HCl ...
Cached Medicine Technology:TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH 2BioCryst Provides Forodesine HCl Update 2BioCryst Provides Forodesine HCl Update 3BioCryst Provides Forodesine HCl Update 4BioCryst Provides Forodesine HCl Update 5
(Date:8/22/2014)... According to the new research report "Isocyanate ... & Forecast to 2019" defines and segments the ... the market value. The isocyanate material market value ... a significant CAGR from 2014 to 2019. , ... spread through 286 pages and in-depth TOC on ...
(Date:8/22/2014)... the leading pan-European organisation representing medical oncology professionals, ... receiving the Society,s esteemed annual awards. The awards ... and Peter Boyle on the occasion of the ... Carsten Bokemeyer will receive the ESMO Award for ... discovery into real benefit at patient level. 1 ...
(Date:8/22/2014)... 2014 The report "Higher Education ... & Compliance, Campus Technology, Student & Curriculum, Performance ... defines and segments the global Higher Ed market ... forecasting of market sizes. The report also identifies ... opportunities impacting it along with the adoption trends. ...
(Date:8/22/2014)... 2014 A new study finds a wide range ... be related to key environmental exposuresin children with Crohn,s disease ... journal of the Crohn,s & Colitis Foundation of America ... Williams & Wilkins , a part of Wolters Kluwer ... of alterations of DNA in several regions of the genome ...
(Date:8/22/2014)... of Alzheimer,s disease can be slowed and some ... that is found in pomegranate. Also, the ... arthritis and Parkinson,s disease could be reduced, according ... by University of Huddersfield scientist Dr Olumayokun Olajide, ... products. , Now, a new phase of research ...
Breaking Medicine News(10 mins):Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 3Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 4Health News:ESMO honors outstanding oncology professionals 2Health News:ESMO honors outstanding oncology professionals 3Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Higher Education Market Worth $65.83 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Study shows epigenetic changes in children with Crohn's disease 2Health News:Research underway to create pomegranate drug to stem Alzheimer's and Parkinson's 2
... In a new reflection on the dangers currently gripping humanity, ... to invest in public health and not arms. ... any noble heart, said Castro in his recent article broadcast ... feature, Castro condemned the construction of a "wonderful submarine" in ...
... far better than drinking water, researchers said. ,There ... cups of tea can reduce the risk of heart attacks. ... King's College London, it is a wrong belief that tea ... as it contains antioxidants. It does not dehydrate you, Mirror ...
... a new outbreak of avian flu at three poultry farms ... ,Laboratory tests confirmed the presence of H5N1, a ... three farms in Chak Shehzad, where about 12,000 birds died ... and Livestock Ministry. ,There were no reports of ...
... combination asthma therapy, SYMBICORT leads to significant improvements ... patient-reported satisfaction with asthma treatment, versus its ... ,SYMBICORT is a recently approved, combination therapy indicated ... patients 12 years of age and older. SYMBICORT ...
... comprehensive survey carried out by the World Conservation Union (IUCN) ... threatened with extinction. ,Unless the trend is ... able to meet its self-imposed target of halting biodiversity loss ... that live in Europe and western Russia, some 15 percent ...
... at Arizona State University has used molecular biology tricks to ... with the ones that occurred naturally. ... new proteins in a fraction of the three billion years ... led to some surprisingly new lessons on how to optimize ...
Cached Medicine News:Health News:Combo Therapy may Be Highly Beneficial in Asthma Control 2Health News:One-sixth of Europe's Mammals Face Extinction, Warns Conservation Experts 2
... and fourth year medical students on ... easy access in a rapid-fire Q&A ... lab coat pocket, this reference is ... prior to surgical rounds as well ...
With its extensive content and custom-designed user interface, Schwartz Principles of Surgery, PDA Edition enables you quick access to the answers you need to make the right diagnosis or initiate a t...
This handy reference contains all of the essential information that surgical residents and medical students need to have at their fingertips for day-to-day patient care....
This book includes orthopedic, reproductive, renal, cardiovascular, GI, and respiratory problems; and other common conditions....
Medicine Products: